Denali Capital Acquisition Corp.
Status: Live Deal
U=S+W
W=S@11.50
IPO Proceeds, $M | $82.50M |
---|---|
IPO Date | Apr 7, 2022 |
CEO | Lei Huang |
Left Lead | Tiger Brokers |
IPO Cash in Trust | 102.0% |
SPAC Tenor | 12 + 3 + 3 + 9 + 9 + 8 |
IPO Sector | General ▶ |
IPO Geography | Global |
Target Company | Semnur Pharmaceuticals |
Deal Announced | Sep 3, 2024 |
Deal Size, $M | TBD |
Deal Sector | Healthcare |
Deal Geography | US/Canada |
SEC Filings |
www.sec.gov |
Approval Vote | TBD |
Amendment Vote | Apr 11, 2025 |
DNQAF
DNQUF
DNQWF
Price | $12.99 |
---|---|
Last closing price | $12.99 |
H/L, today | $12.99 / $12.99 |
Volume, today | 1 |
Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.